1α,25-Dihydroxyvitamin D3 synergistically enhances anticancer effects of ginsenoside Rh2 in human prostate cancer cells

被引:12
作者
Ben-Eltriki, Mohamed [1 ,2 ]
Deb, Subrata [3 ]
Guns, Emma S. Tomlinson [1 ]
机构
[1] Vancouver Gen Hosp, Vancouver Prostate Ctr, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada
[2] Univ British Columbia, Fac Med, Dept Anesthesiol Pharmacol & Therapeut, Therapeut Initiat, Vancouver, BC, Canada
[3] Larkin Univ, Coll Pharm, Dept Pharmaceut Sci, 18301 N Miami Ave, Miami, FL 33169 USA
关键词
1 alpha,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3); Ginsenoside Rh2; Prostate cancer; Synergism; Vitamin D receptor; ACTIVITY IN-VITRO; VITAMIN-D; ANTITUMOR-ACTIVITY; NATURAL-PRODUCT; HUMAN LIVER; CALCITRIOL; DOCETAXEL; COMBINATION; INHIBITION; MECHANISMS;
D O I
10.1016/j.jsbmb.2021.105828
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1 alpha,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3, commonly known as calcitriol), the most active metabolite of vitamin D3, and ginsenoside Rh2 can regulate cellular differentiation and proliferation proteins. The purpose of the present study was to assess the effect of 1,25(OH)(2)D-3 on the anticancer activities of Rh2 in human prostate cancer cells such as androgen-dependent LNCaP and androgen-independent C4-2 in vitro. The effects of treatment with 1,25(OH)(2)D-3 or Rh2, either alone or in combination, on prostate cancer cells were evaluated through tetrazolium-based cell viability assay, BrdU cell proliferation rate estimation assay, and Western blot protein expression analyses of nuclear receptors (androgen receptor and vitamin D receptors) and apoptotic proteins (Bcl-2, Bax, and Caspase 3). The Combination Indices (CI) and Dose Reduction Indices (DRI) of 1,25(OH)(2)D-3 and Rh2 were calculated to determine synergistic anticancer activity using Calcusyn software (Biosoft, Cambridge, UK). The cell viability assay data indicate that Rh2 treatment alone inhibited cell viability in a concentration-dependent manner and the addition of 10 nM 1,25(OH)(2)D-3 to Rh2 significantly enhanced its ability to reduce cell viability up to 80 % in both the cell lines. Similarly, addition of 10 nM 1,25(OH)(2)D-3 to Rh2 significantly lowered its IC50 values for cell proliferation from the range of 32-65 mu M to 14-8 mu M in LNCaP and C4-2 cells. In addition, protein expression analyses indicated that the combined treatment with Rh2 and 1,25(OH)(2)D-3 led to greater downregulation of androgen receptor expression compared to single agent exposure. Similarly, the presence of 1,25(OH)(2)D-3 synergistically increased the pro-apoptotic actions of Rh2 in both the cell lines. Overall, 1,25(OH)(2)D-3 augments the Rh2-mediated anticancer effects through stimulating apoptosis and reduced cell proliferation which suggests that synergism of this combination may lead to potential lower need of the active vitamin D-3 and limited toxicity from it.
引用
收藏
页数:9
相关论文
共 41 条
[1]   Effect of calcitriol on prostate-specific antigen in vitro and in humans [J].
Beer, TM ;
Garzotto, M ;
Park, B ;
Mori, M ;
Myrthue, A ;
Janeba, N ;
Sauer, D ;
Eilers, K .
CLINICAL CANCER RESEARCH, 2006, 12 (09) :2812-2816
[2]  
Ben-Eltriki Mohamed, 2018, Oncotarget, V9, P20965, DOI 10.18632/oncotarget.24695
[3]   Calcitriol and 20(S)-protopanaxadiol synergistically inhibit growth and induce apoptosis in human prostate cancer [J].
Ben-Eltriki, Mohamed ;
Deb, Subrata ;
Adomat, Hans ;
Guns, Emma S. Tomlinson .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2016, 158 :207-219
[4]   Calcitriol in Combination Therapy for Prostate Cancer: Pharmacokinetic and Pharmacodynamic Interactions [J].
Ben-Eltriki, Mohamed ;
Deb, Subrata ;
Guns, Emma S. Tomlinson .
JOURNAL OF CANCER, 2016, 7 (04) :391-407
[5]   Vitamin D Metabolism, Mechanism of Action, and Clinical Applications [J].
Bikle, Daniel D. .
CHEMISTRY & BIOLOGY, 2014, 21 (03) :319-329
[6]   20(S)-protopanaxadiol-aglycone downregulation of the full-length and splice variants of androgen receptor [J].
Cao, Bo ;
Liu, Xichun ;
Li, Jing ;
Liu, Shuang ;
Qi, Yanfeng ;
Xiong, Zhenggang ;
Zhang, Allen ;
Wiese, Thomas ;
Fu, Xueqi ;
Gu, Jingkai ;
Rennie, Paul S. ;
Sartor, Oliver ;
Lee, Benjamin R. ;
Ip, Clement ;
Zhao, Lijuan ;
Zhang, Haitao ;
Dong, Yan .
INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (06) :1277-1287
[7]   Identification of human cytochrome P450 enzymes involved in the hepatic and intestinal biotransformation of 20(S)-protopanaxadiol [J].
Chiu, Nga Ting Colette ;
Guns, Emma S. Tomlinson ;
Adomat, Hans ;
Jia, William ;
Deb, Subrata .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2014, 35 (02) :104-118
[8]   Ginsenoside-mediated blockade of 1α,25-dihydroxyvitamin D3 inactivation in human liver and intestine in vitro [J].
Deb, Subrata ;
Chin, Mei Yieng ;
Adomat, Hans ;
Guns, Emma S. Tomlinson .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2014, 141 :94-103
[9]   Cytochrome P450 3A-Mediated Microsomal Biotransformation of 1α,25-Dihydroxyvitamin D3 in Mouse and Human Liver: Drug-Related Induction and Inhibition of Catabolism [J].
Deb, Subrata ;
Pandey, Mitali ;
Adomat, Hans ;
Guns, Emma S. Tomlinson .
DRUG METABOLISM AND DISPOSITION, 2012, 40 (05) :907-918
[10]   Vitamin D signalling pathways in cancer: potential for anticancer therapeutics [J].
Deeb, Kristin K. ;
Trump, Donald L. ;
Johnson, Candace S. .
NATURE REVIEWS CANCER, 2007, 7 (09) :684-700